Trupanion (NASDAQ:TRUP) Shares Up 5%

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report)'s stock price shot up 5% during mid-day trading on Wednesday . The stock traded as high as $23.94 and last traded at $23.89. 235,837 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 673,810 shares. The stock had previously closed at $22.75.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on TRUP. Evercore ISI decreased their target price on Trupanion from $35.00 to $31.00 and set an "outperform" rating for the company in a research report on Tuesday, February 20th. Stifel Nicolaus increased their target price on Trupanion from $25.00 to $28.00 and gave the stock a "hold" rating in a research report on Friday, February 16th. Finally, Piper Sandler decreased their target price on Trupanion from $32.00 to $28.00 and set a "neutral" rating for the company in a research report on Friday, April 5th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $33.20.

Read Our Latest Stock Report on Trupanion

Trupanion Trading Up 5.1 %


The firm has a 50 day simple moving average of $26.10 and a 200 day simple moving average of $26.90. The firm has a market capitalization of $999.80 million, a PE ratio of -21.06 and a beta of 1.71. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.13. The business had revenue of $295.50 million for the quarter, compared to analysts' expectations of $289.84 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The business's quarterly revenue was up 20.1% on a year-over-year basis. During the same period last year, the firm earned ($0.23) earnings per share. Equities analysts expect that Trupanion, Inc. will post -0.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. BluePath Capital Management LLC bought a new stake in shares of Trupanion during the third quarter valued at approximately $31,000. Quest Partners LLC bought a new stake in shares of Trupanion during the fourth quarter valued at approximately $67,000. PNC Financial Services Group Inc. raised its stake in shares of Trupanion by 45.4% during the third quarter. PNC Financial Services Group Inc. now owns 2,990 shares of the financial services provider's stock valued at $84,000 after acquiring an additional 933 shares in the last quarter. Victory Capital Management Inc. bought a new stake in shares of Trupanion during the fourth quarter valued at approximately $211,000. Finally, Dark Forest Capital Management LP acquired a new position in shares of Trupanion during the third quarter worth $219,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

Should you invest $1,000 in Trupanion right now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: